These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
452 related articles for article (PubMed ID: 26679962)
1. Asthma Controller Medication Adherence, Risk of Exacerbation, and Use of Rescue Agents Among Texas Medicaid Patients with Persistent Asthma. Makhinova T; Barner JC; Richards KM; Rascati KL J Manag Care Spec Pharm; 2015 Dec; 21(12):1124-32. PubMed ID: 26679962 [TBL] [Abstract][Full Text] [Related]
2. Adequate levels of adherence with controller medication is associated with increased use of rescue medication in asthmatic children. Elkout H; Helms PJ; Simpson CR; McLay JS PLoS One; 2012; 7(6):e39130. PubMed ID: 22761728 [TBL] [Abstract][Full Text] [Related]
3. Economic Burden of Illness Among Patients with Severe Asthma in a Managed Care Setting. Chastek B; Korrer S; Nagar SP; Albers F; Yancey S; Ortega H; Forshag M; Dalal AA J Manag Care Spec Pharm; 2016 Jul; 22(7):848-61. PubMed ID: 27348285 [TBL] [Abstract][Full Text] [Related]
4. Primary adherence to controller medications for asthma is poor. Wu AC; Butler MG; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Miroshnik I; Davis RL; Lieu TA; Soumerai SB Ann Am Thorac Soc; 2015 Feb; 12(2):161-6. PubMed ID: 25569765 [TBL] [Abstract][Full Text] [Related]
5. Seasonal patterns of controller and rescue medication dispensed in underserved children with asthma. Butz AM; Thompson RE; Tsoukleris MG; Donithan M; Hsu VD; Mudd K; Zuckerman IH; Bollinger ME J Asthma; 2008 Nov; 45(9):800-6. PubMed ID: 18972299 [TBL] [Abstract][Full Text] [Related]
6. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States. Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167 [TBL] [Abstract][Full Text] [Related]
7. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients. Navaratnam P; Friedman HS; Urdaneta E Value Health; 2011; 14(2):339-46. PubMed ID: 21402302 [TBL] [Abstract][Full Text] [Related]
8. Impact of asthma controller medications on clinical, economic, and patient-reported outcomes. Tan H; Sarawate C; Singer J; Elward K; Cohen RI; Smart BA; Busk MF; Lustig J; O'Brien JD; Schatz M Mayo Clin Proc; 2009 Aug; 84(8):675-84. PubMed ID: 19648384 [TBL] [Abstract][Full Text] [Related]
10. Controller Medication Use and Exacerbations for Children and Adults With Asthma in High-Deductible Health Plans. Galbraith AA; Ross-Degnan D; Zhang F; Wu AC; Sinaiko A; Peltz A; Xu X; Wallace J; Wharam JF JAMA Pediatr; 2021 Aug; 175(8):807-816. PubMed ID: 33970186 [TBL] [Abstract][Full Text] [Related]
11. ADHD medication use, adherence, persistence and cost among Texas Medicaid children. Barner JC; Khoza S; Oladapo A Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228 [TBL] [Abstract][Full Text] [Related]
12. High oral corticosteroid exposure and overuse of short-acting beta-2-agonists were associated with insufficient prescribing of controller medication: a nationwide electronic prescribing and dispensing database analysis. Sá-Sousa A; Almeida R; Vicente R; Nascimento N; Martins H; Freitas A; Fonseca JA Clin Transl Allergy; 2019; 9():47. PubMed ID: 31559008 [TBL] [Abstract][Full Text] [Related]
13. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization. Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972 [TBL] [Abstract][Full Text] [Related]
14. Underuse of controller medications among children with persistent asthma in the Ohio medicaid population: evolving differences with new medications. Wilson SE; Leonard A; Moomaw C; Schneeweiss S; Eckman MH Ambul Pediatr; 2005; 5(2):83-9. PubMed ID: 15780019 [TBL] [Abstract][Full Text] [Related]
15. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139 [TBL] [Abstract][Full Text] [Related]
16. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of risk factors and health outcomes among persons with asthma. Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629 [TBL] [Abstract][Full Text] [Related]
18. Overprescription of short-acting β Al Zaabi A; Busaidi N; Al Mutairy S; Yorgancıoğlu A; Aksu K; Al-Jahdali H; Wali S; Elsayed M; Beekman MJ Expert Rev Respir Med; 2022 Jul; 16(7):833-847. PubMed ID: 35848074 [TBL] [Abstract][Full Text] [Related]
19. Patient Outcomes, Health Care Resource Use, and Costs Associated with High Versus Low HEDIS Asthma Medication Ratio. Luskin AT; Antonova EN; Broder MS; Chang E; Raimundo K; Solari PG J Manag Care Spec Pharm; 2017 Nov; 23(11):1117-1124. PubMed ID: 29083971 [TBL] [Abstract][Full Text] [Related]
20. Assessment of basal insulin adherence using 2 methodologies among Texas Medicaid enrollees with type 2 diabetes. Zhang H; Barner JC; Moczygemba LR; Rascati KL J Manag Care Spec Pharm; 2020 Nov; 26(11):1434-1444. PubMed ID: 33119450 [No Abstract] [Full Text] [Related] [Next] [New Search]